BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 16248846)

  • 1. Diversity of senile plaques in Alzheimer's disease as revealed by a new monoclonal antibody that recognizes an internal sequence of the Abeta peptide.
    Rábano A; Jiménez-Huete A; Acevedo B; Calero M; Ghiso J; Valdés I; Gavilondo J; Frangione B; Méndez E
    Curr Alzheimer Res; 2005 Oct; 2(4):409-17. PubMed ID: 16248846
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pyroglutamation of amyloid-βx-42 (Aβx-42) followed by Aβ1-40 deposition underlies plaque polymorphism in progressing Alzheimer's disease pathology.
    Michno W; Nyström S; Wehrli P; Lashley T; Brinkmalm G; Guerard L; Syvänen S; Sehlin D; Kaya I; Brinet D; Nilsson KPR; Hammarström P; Blennow K; Zetterberg H; Hanrieder J
    J Biol Chem; 2019 Apr; 294(17):6719-6732. PubMed ID: 30814252
    [TBL] [Abstract][Full Text] [Related]  

  • 3. beta-amyloid deposits in transgenic mice expressing human beta-amyloid precursor protein have the same characteristics as those in Alzheimer's disease.
    Terai K; Iwai A; Kawabata S; Tasaki Y; Watanabe T; Miyata K; Yamaguchi T
    Neuroscience; 2001; 104(2):299-310. PubMed ID: 11377835
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Generation and Partial Characterization of Rabbit Monoclonal Antibody to Pyroglutamate Amyloid-β3-42 (pE3-Aβ).
    Mehta PD; Patrick BA; Barshatzky M; Mehta SP; Frackowiak J; Mazur-Kolecka B; Wegiel J; Wisniewski T; Miller DL
    J Alzheimers Dis; 2018; 62(4):1635-1649. PubMed ID: 29504532
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High sensitivity analysis of amyloid-beta peptide composition in amyloid deposits from human and PS2APP mouse brain.
    Güntert A; Döbeli H; Bohrmann B
    Neuroscience; 2006 Dec; 143(2):461-75. PubMed ID: 17008022
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mostly separate distributions of CLAC- versus Abeta40- or thioflavin S-reactivities in senile plaques reveal two distinct subpopulations of beta-amyloid deposits.
    Kowa H; Sakakura T; Matsuura Y; Wakabayashi T; Mann DM; Duff K; Tsuji S; Hashimoto T; Iwatsubo T
    Am J Pathol; 2004 Jul; 165(1):273-81. PubMed ID: 15215182
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterization of new polyclonal antibodies specific for 40 and 42 amino acid-long amyloid beta peptides: their use to examine the cell biology of presenilins and the immunohistochemistry of sporadic Alzheimer's disease and cerebral amyloid angiopathy cases.
    Barelli H; Lebeau A; Vizzavona J; Delaere P; Chevallier N; Drouot C; Marambaud P; Ancolio K; Buxbaum JD; Khorkova O; Heroux J; Sahasrabudhe S; Martinez J; Warter JM; Mohr M; Checler F
    Mol Med; 1997 Oct; 3(10):695-707. PubMed ID: 9392006
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Development and characterization of a monoclonal antibody 369.2B specific for the carboxyl-terminus of the beta A4 peptide.
    König G; Graham P; Bushnell A; Webster S; Wunderlich D; Perlmutter LS
    Ann N Y Acad Sci; 1996 Jan; 777():344-55. PubMed ID: 8624111
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Generation and Partial Characterization of Rabbit Monoclonal Antibody to Amyloid-β Peptide 1-37 (Aβ37).
    Mehta PD; Blain JF; Freeman EA; Patrick BA; Barshatzky M; Hrdlicka LA; Mehta SP; Frackowiak J; Mazur-Kolecka B; Wegiel J; Patzke H; Miller DL
    J Alzheimers Dis; 2017; 57(1):135-145. PubMed ID: 28222530
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of peptides that specifically bind Abeta1-40 amyloid in vitro and amyloid plaques in Alzheimer's disease brain using phage display.
    Kang CK; Jayasinha V; Martin PT
    Neurobiol Dis; 2003 Oct; 14(1):146-56. PubMed ID: 13678675
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Correlation between Abetax-40-, Abetax-42-, and Abetax-43-containing amyloid plaques and cognitive decline.
    Parvathy S; Davies P; Haroutunian V; Purohit DP; Davis KL; Mohs RC; Park H; Moran TM; Chan JY; Buxbaum JD
    Arch Neurol; 2001 Dec; 58(12):2025-32. PubMed ID: 11735776
    [TBL] [Abstract][Full Text] [Related]  

  • 12. N-terminal heterogeneity of parenchymal and cerebrovascular Abeta deposits.
    Tekirian TL; Saido TC; Markesbery WR; Russell MJ; Wekstein DR; Patel E; Geddes JW
    J Neuropathol Exp Neurol; 1998 Jan; 57(1):76-94. PubMed ID: 9600199
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparative analysis of amyloid-beta chemical structure and amyloid plaque morphology of transgenic mouse and Alzheimer's disease brains.
    Kuo YM; Kokjohn TA; Beach TG; Sue LI; Brune D; Lopez JC; Kalback WM; Abramowski D; Sturchler-Pierrat C; Staufenbiel M; Roher AE
    J Biol Chem; 2001 Apr; 276(16):12991-8. PubMed ID: 11152675
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Alzheimer's disease.
    De-Paula VJ; Radanovic M; Diniz BS; Forlenza OV
    Subcell Biochem; 2012; 65():329-52. PubMed ID: 23225010
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A novel monoclonal antibody against the N-terminus of Aβ1-42 reduces plaques and improves cognition in a mouse model of Alzheimer's disease.
    Xing HY; Li B; Peng D; Wang CY; Wang GY; Li P; Le YY; Wang JM; Ye G; Chen JH
    PLoS One; 2017; 12(6):e0180076. PubMed ID: 28662102
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Alzheimer's disease abeta vaccine reduces central nervous system abeta levels in a non-human primate, the Caribbean vervet.
    Lemere CA; Beierschmitt A; Iglesias M; Spooner ET; Bloom JK; Leverone JF; Zheng JB; Seabrook TJ; Louard D; Li D; Selkoe DJ; Palmour RM; Ervin FR
    Am J Pathol; 2004 Jul; 165(1):283-97. PubMed ID: 15215183
    [TBL] [Abstract][Full Text] [Related]  

  • 17. N-truncated Aβ
    Wirths O; Walter S; Kraus I; Klafki HW; Stazi M; Oberstein TJ; Ghiso J; Wiltfang J; Bayer TA; Weggen S
    Alzheimers Res Ther; 2017 Oct; 9(1):80. PubMed ID: 28978359
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A cyclic undecamer peptide mimics a turn in folded Alzheimer amyloid β and elicits antibodies against oligomeric and fibrillar amyloid and plaques.
    Hoogerhout P; Kamphuis W; Brugghe HF; Sluijs JA; Timmermans HA; Westdijk J; Zomer G; Boog CJ; Hol EM; van den Dobbelsteen GP
    PLoS One; 2011 Apr; 6(4):e19110. PubMed ID: 21526148
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Monoclonal antibody to the C-terminus of beta-amyloid.
    Yang F; Mak K; Vinters HV; Frautschy SA; Cole GM
    Neuroreport; 1994 Oct; 5(16):2117-20. PubMed ID: 7865758
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chemical imaging of evolving amyloid plaque pathology and associated Aβ peptide aggregation in a transgenic mouse model of Alzheimer's disease.
    Michno W; Wehrli P; Meier SR; Sehlin D; Syvänen S; Zetterberg H; Blennow K; Hanrieder J
    J Neurochem; 2020 Mar; 152(5):602-616. PubMed ID: 31605538
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.